{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:07:28Z","timestamp":1773950848147,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008722","name":"Universitat de Girona","doi-asserted-by":"crossref","award":["MPCUdG2016\/036"],"award-info":[{"award-number":["MPCUdG2016\/036"]}],"id":[{"id":"10.13039\/100008722","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["SAF2017-88076-R"],"award-info":[{"award-number":["SAF2017-88076-R"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RD06\/0010\/0006"],"award-info":[{"award-number":["RD06\/0010\/0006"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s12035-020-02041-x","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T07:02:32Z","timestamp":1596610952000},"page":"4549-4562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington\u2019s Disease Mice Are Related to Cognitive Dysfunction"],"prefix":"10.1007","volume":"57","author":[{"given":"Laura","family":"Vidal-Sancho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Sol\u00e9s-Tarr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7417-9475","authenticated-orcid":false,"given":"Xavier","family":"Xifr\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"2041_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"2041_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","volume":"25","author":"JC Stout","year":"2011","unstructured":"Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K et al (2011) Neurocognitive signs in prodromal Huntington disease. Neuropsychology 25:1\u201314","journal-title":"Neuropsychology"},{"key":"2041_CR3","first-page":"21","volume":"31","author":"A Montoya","year":"2006","unstructured":"Montoya A, Price BH, Menear M, Lepage M (2006) Brain imaging and cognitive dysfunctions in Huntington\u2019s disease. J Psychiatry Neurosci 31:21\u201329","journal-title":"J Psychiatry Neurosci"},{"key":"2041_CR4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"2041_CR5","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","volume":"119","author":"AD Lawrence","year":"1996","unstructured":"Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW (1996) Executive and mnemonic functions in early Huntington\u2019s disease. Brain 119:1633\u20131645","journal-title":"Brain"},{"key":"2041_CR6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cortex.2019.07.014","volume":"119","author":"KL Harris","year":"2019","unstructured":"Harris KL, Armstrong M, Swain R, Erzinclioglu S, Das T, Burgess N, Barker RA, Mason SL (2019) Huntington\u2019s disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory. Cortex 119:417\u2013427","journal-title":"Cortex"},{"key":"2041_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JHD-120023","volume":"1","author":"A Giralt","year":"2012","unstructured":"Giralt A, Saavedra A, Alberch J, P\u00e9rez-Navarro E (2012) Cognitive dysfunction in Huntington\u2019s disease: humans, mouse models and molecular mechanisms. J Huntingtons Dis 1:155\u2013173","journal-title":"J Huntingtons Dis"},{"key":"2041_CR8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/14728222.2018.1465930","volume":"22","author":"A Saavedra","year":"2018","unstructured":"Saavedra A, Garc\u00eda-D\u00edaz Barriga G, P\u00e9rez-Navarro E, Alberch J (2018) Huntington\u2019s disease: novel therapeutic perspectives hanging in the balance. Expert Opin Ther Targets 22:385\u2013399","journal-title":"Expert Opin Ther Targets"},{"key":"2041_CR9","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/hmg\/ddl092","volume":"15","author":"AJ Milnerwood","year":"2006","unstructured":"Milnerwood AJ, Cummings DM, Dallerac GM, Brown JY, Vatsavayai SC, Hirst MC, Rezaie P, Murphy KP (2006) Early development of aberrant synaptic plasticity in a mouse model of Huntington\u2019s disease. Hum Mol Genet 15:1690\u20131703","journal-title":"Hum Mol Genet"},{"key":"2041_CR10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.brainresbull.2011.07.021","volume":"88","author":"KR Bowles","year":"2012","unstructured":"Bowles KR, Brooks SP, Dunnett SB, Jones L (2012) Gene expression and behaviour in mouse models of HD. Brain Res Bull 88:276\u2013284","journal-title":"Brain Res Bull"},{"key":"2041_CR11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2007.11.006","volume":"29","author":"J Nithianantharajah","year":"2008","unstructured":"Nithianantharajah J, Barkus C, Murphy M, Hannan AJ (2008) Gene\u2013environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington\u2019s disease transgenic mice. Neurobiol Dis 29:490\u2013504","journal-title":"Neurobiol Dis"},{"key":"2041_CR12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","volume":"23","author":"JH Cha","year":"2000","unstructured":"Cha JH (2000) Transcriptional dysregulation in Huntington\u2019s disease. Trends Neurosci 23:387\u2013392","journal-title":"Trends Neurosci"},{"key":"2041_CR13","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1007\/s12035-018-0972-5","volume":"55","author":"N Cabezas-Llobet","year":"2018","unstructured":"Cabezas-Llobet N, Vidal-Sancho L, Masana M, Fournier A, Alberch J, Vaudry D, Xifr\u00f3 X (2018) Pituitary adenylate cyclase-activating polypeptide (PACAP) enhances hippocampal synaptic plasticity and improves memory performance in Huntington\u2019s disease. Mol Neurobiol 55:8263\u20138277","journal-title":"Mol Neurobiol"},{"key":"2041_CR14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","volume":"21","author":"A Giralt","year":"2012","unstructured":"Giralt A, Puigdell\u00edvol M, Carret\u00f3n O, Paoletti P, Valero J, Parradamas A, Saura CA, Alberch J et al (2012) Long-term memory deficits in Huntington\u2019s disease are associated with reduced CBP histone acetylase activity. Hum Mol Genet 21:1203\u20131216","journal-title":"Hum Mol Genet"},{"key":"2041_CR15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jnc.14555","volume":"147","author":"JG Doria","year":"2018","unstructured":"Doria JG, de Souza JM, Silva FR, Olmo IG, Carvalho TG, Alves-Silva J, Ferreira-Vieira TH, Santos JT et al (2018) The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington\u2019s disease. J Neurochem 147:222\u2013239","journal-title":"J Neurochem"},{"key":"2041_CR16","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","volume":"158","author":"A Giralt","year":"2009","unstructured":"Giralt A, Rodrigo T, Mart\u00edn ED, Gonzalez JR, Mil\u00e0 M, Ce\u00f1a V, Dierssen M, Canals JM et al (2009) Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipase C gamma activity and glutamate receptor expression. Neuroscience 158:1234\u20131250","journal-title":"Neuroscience"},{"key":"2041_CR17","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","volume":"27","author":"G Lynch","year":"2007","unstructured":"Lynch G, Kramar EA, Rex CS, Jia Y, Chappas D, Gall CM, Simmons DA (2007) Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington\u2019s disease. J Neurosci 27:4424\u20134434","journal-title":"J Neurosci"},{"key":"2041_CR18","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1242\/dev.008367","volume":"134","author":"MJ Potthoff","year":"2007","unstructured":"Potthoff MJ, Olson EN (2007) MEF2: a central regulator of diverse developmental programs. Development 134:4131\u20134140","journal-title":"Development"},{"key":"2041_CR19","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1523\/JNEUROSCI.15-08-05727.1995","volume":"15","author":"GE Lyons","year":"1995","unstructured":"Lyons GE, Micales BK, Schwarz J, Martin JF, Olson EN (1995) Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J Neurosci 15:5727\u20135738","journal-title":"J Neurosci"},{"key":"2041_CR20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1523\/JNEUROSCI.21-02-00434.2001","volume":"21","author":"JE Cavanaugh","year":"2001","unstructured":"Cavanaugh JE, Ham J, Hetman M, Poser S, Yan C, Xia Z (2001) Differential regulation of mitogen activated protein kinases ERK1\/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons. J Neurosci 21:434\u2013443","journal-title":"J Neurosci"},{"key":"2041_CR21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.286.5440.785","volume":"286","author":"Z Mao","year":"1999","unstructured":"Mao Z (1999) Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286:785\u2013790","journal-title":"Science"},{"key":"2041_CR22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2012.09.037","volume":"151","author":"R Sando","year":"2012","unstructured":"Sando R, Gounko N, Pieraut S, Liao L, Yates J, Maximov A (2012) HDAC4 governs a transcriptional program essential for synaptic plasticity and memory. Cell 151:821\u2013834","journal-title":"Cell"},{"key":"2041_CR23","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1093\/emboj\/18.18.5099","volume":"18","author":"E Miska","year":"1999","unstructured":"Miska E, Karlsson C, Langley E, Nielsen SJ, Pines J, Kouzarides T (1999) HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J 18:5099\u20135107","journal-title":"EMBO J"},{"key":"2041_CR24","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.neuron.2008.11.029","volume":"60","author":"SW Flavell","year":"2008","unstructured":"Flavell SW, Kim TK, Gray JM, Harmin D, Hemberg M, Hong EJ, Markenscoff-Papadimitriou E, Bear DM et al (2008) Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 60:1022\u20131038","journal-title":"Neuron"},{"key":"2041_CR25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/emboj.2009.10","volume":"28","author":"R Fiore","year":"2009","unstructured":"Fiore R, Khudayberdiev S, Christensen M, Siegel G, Flavell SW, Kim TK, Greenberg ME, Schratt G (2009) Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J 28:697\u2013710","journal-title":"EMBO J"},{"key":"2041_CR26","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1126\/science.1122511","volume":"311","author":"SW Flavell","year":"2006","unstructured":"Flavell SW, Cowan CW, Kim TK, Greer PL, Lin Y, Paradis S, Griffith EC, Hu LS et al (2006) Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311:1008\u20131012","journal-title":"Science"},{"key":"2041_CR27","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/nn.3189","volume":"15","author":"CJ Cole","year":"2012","unstructured":"Cole CJ, Mercaldo V, Restivo L, Yiu AP, Sekeres MJ, Han JH, Vetere G, Pekar T et al (2012) MEF2 negatively regulates learning-induced structural plasticity and memory formation. Nat Neurosci 15:1255\u20131264","journal-title":"Nat Neurosci"},{"key":"2041_CR28","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1073\/pnas.0802679105","volume":"105","author":"AC Barbosa","year":"2008","unstructured":"Barbosa AC, Kim MS, Ertunc M, Adachi M, Nelson ED, McAnally J, Richardson JA, Kavalali ET et al (2008) MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc Natl Acad Sci U S A 105:9391\u20139396","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2041_CR29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.nbd.2010.08.022","volume":"41","author":"Y Chu","year":"2011","unstructured":"Chu Y, Mickiewicz AL, Kordower JH (2011) \u03b1-Synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson\u2019s disease. Neurobiol Dis 41:71\u201382","journal-title":"Neurobiol Dis"},{"key":"2041_CR30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","volume":"155","author":"SD Ryan","year":"2013","unstructured":"Ryan SD, Dolatabadi N, Chan SF, Zhang X, Akhtar MW, Parker J, Soldner F, Sunico CR et al (2013) Isogenic human iPSC Parkinson\u2019s model shows nitrosative stress-induced dysfunction in MEF2-PGC1\u03b1 transcription. Cell 155:1351\u20131364","journal-title":"Cell"},{"key":"2041_CR31","doi-asserted-by":"crossref","first-page":"29186","DOI":"10.1074\/jbc.M704182200","volume":"282","author":"T Bolger","year":"2007","unstructured":"Bolger T, Zhao X, Cohen TJ, Tsai CC, Yao TP (2007) The neurodegenerative disease protein ataxin-1 antagonizes the neuronal survival function of myocyte enhancer factor-2. J Biol Chem 282:29186\u201329192","journal-title":"J Biol Chem"},{"key":"2041_CR32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"2041_CR33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, Ryan A, Duyao MP, Vrbanac V et al (1999) Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mouse. Hum Mol Genet 8:115\u2013122","journal-title":"Hum Mol Genet"},{"key":"2041_CR34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2015.09.001","volume":"95","author":"M Anglada-Huguet","year":"2016","unstructured":"Anglada-Huguet M, Vidal-Sancho L, Giralt A, Garc\u00eda-D\u00edaz Barriga G, Xifr\u00f3 X, Alberch J (2016) Prostaglandin E2 EP2 activation reduces memory decline in R6\/1 mouse model of Huntington\u2019s disease by the induction of BDNF-dependent synaptic plasticity. Neurobiol Dis 95:22\u201334","journal-title":"Neurobiol Dis"},{"key":"2041_CR35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1750-1326-6-74","volume":"6","author":"X Xifr\u00f3","year":"2011","unstructured":"Xifr\u00f3 X, Anglada-Huguet M, Ru\u00e9 L, Saavedra A, P\u00e9rez-Navarro E, Alberch J (2011) Increased 90kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity. Mol Neurodegener 6:74","journal-title":"Mol Neurodegener"},{"key":"2041_CR36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s12035-013-8556-x","volume":"49","author":"M Anglada-Huguet","year":"2014","unstructured":"Anglada-Huguet M, Xifr\u00f3 X, Giralt A, Zamora-Moratalla A, Mart\u00edn ED, Alberch J (2014) Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6\/1 mouse model of Huntington\u2019s disease. Mol Neurobiol 49:784\u2013795","journal-title":"Mol Neurobiol"},{"key":"2041_CR37","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.2012.07711.x","volume":"121","author":"M Anglada-Huguet","year":"2012","unstructured":"Anglada-Huguet M, Giralt A, Perez-Navarro E, Alberch J, Xifr\u00f3 X (2012) Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington\u2019s disease. J Neurochem 121:639\u2013648","journal-title":"J Neurochem"},{"key":"2041_CR38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19:233\u2013238","journal-title":"Trends Genet"},{"key":"2041_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cell.2012.08.028","volume":"151","author":"SX Chen","year":"2012","unstructured":"Chen SX, Cherry A, Tari PK, Podgorski K, Kwong YKK, Haas K (2012) The transcription factor MEF2 directs developmental visually driven functional and structural metaplasticity. Cell 151:41\u201355","journal-title":"Cell"},{"key":"2041_CR40","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1093\/nar\/gks189","volume":"40","author":"N Jayathilaka","year":"2012","unstructured":"Jayathilaka N, Han A, Gaffney KJ, Dey R, Jarusiewicz J, Noridomi K, Philips MA, Lei X et al (2012) Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2. Nucleic Acids Res 40:5378\u20135388","journal-title":"Nucleic Acids Res"},{"key":"2041_CR41","doi-asserted-by":"crossref","first-page":"e0143563","DOI":"10.1371\/journal.pone.0143563","volume":"10","author":"A Labadorf","year":"2015","unstructured":"Labadorf A, Hoss AG, Lagomarsino V, Latourelle JC, Hadzi TC, Bregu J, MacDonald ME, Gusella JF et al (2015) RNA sequence analysis of human Huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression. PLoS One 10:e0143563","journal-title":"PLoS One"},{"key":"2041_CR42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuropharm.2017.08.014","volume":"126","author":"B Guo","year":"2017","unstructured":"Guo B, Hu S, Zheng C, Wang H, Luo F, Li H, Cui W, Yang X et al (2017) Substantial protection against MPTP-associated Parkinson\u2019s neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B. Neuropharmacol 126:12\u201324","journal-title":"Neuropharmacol"},{"key":"2041_CR43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/pcn.12618","volume":"72","author":"T Sao","year":"2018","unstructured":"Sao T, Yoshino Y, Yamazaki K, Ozaki Y, Mori Y, Ochi S, Yoshida T, Mori T et al (2018) MEF2C mRNA expression and cognitive function in Japanese patients with Alzheimer\u2019s disease. Psychiatry Clin Neurosci 72:160\u2013167","journal-title":"Psychiatry Clin Neurosci"},{"key":"2041_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.201488327","volume":"33","author":"A Martorell-Riera","year":"2014","unstructured":"Martorell-Riera A, Segarra-Mondejar M, Mu\u00f1oz JP, Ginet V, Olloquequi J, P\u00e9rez-Clausell J, Palac\u00edn M, Reina M et al (2014) Mfn2 downregulation in excitotoxicity causes mitochondrial dysfunction and delayed neuronal death. EMBO J 33:1\u201320","journal-title":"EMBO J"},{"key":"2041_CR45","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.022036399","volume":"99","author":"S Okamoto","year":"2002","unstructured":"Okamoto S, Li Z, Ju C, Scholzke MN, Mathews E, Cui J, Salvesen GS, Bossy-Wetzel E et al (2002) Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis. Proc Natl Acad Sci U S A 99:3974\u20133979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2041_CR46","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1523\/JNEUROSCI.21-17-06544.2001","volume":"21","author":"M Li","year":"2001","unstructured":"Li M, Linseman DA, Allen MP, Meintzer MK, Wang X, Laessig T, Wierman ME, Heidenreich KA (2001) Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons. J Neurosci 21:6544\u20136552","journal-title":"J Neurosci"},{"key":"2041_CR47","first-page":"1","volume":"16","author":"J Brusco","year":"2015","unstructured":"Brusco J, Haas K (2015) Interactions between mitochondria and the transcription factor myocyte enhancer factor 2 (MEF2) regulate neuronal structural and functional plasticity and metaplasticity. J Physiol 16:1\u201325","journal-title":"J Physiol"},{"key":"2041_CR48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuron.2015.08.029","volume":"88","author":"N Unsain","year":"2015","unstructured":"Unsain N, Barker PA (2015) New views on the misconstrued: executioner caspases and their diverse non-apoptotic roles. Neuron 88:461\u2013474","journal-title":"Neuron"},{"key":"2041_CR49","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.neuron.2011.04.004","volume":"70","author":"S Jiao","year":"2011","unstructured":"Jiao S, Li Z (2011) Non-apoptotic function of BAD and BAX in long-term depression of synaptic transmission. Neuron 70:758\u2013772","journal-title":"Neuron"},{"key":"2041_CR50","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cell.2010.03.053","volume":"141","author":"Z Li","year":"2010","unstructured":"Li Z, Jo J, Jia J, Lo S, Whitcomb DJ, Cho K, Sheng M (2010) Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 141:859\u2013871","journal-title":"Cell"},{"key":"2041_CR51","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1093\/hmg\/ddq358","volume":"19","author":"E Marcora","year":"2010","unstructured":"Marcora E, Kennedy MB (2010) The Huntington\u2019s disease mutation impairs Huntingtin\u2019s role in the transport of NF-\u03baB from the synapse to the nucleus. Hum Mol Genet 19:4373\u20134384","journal-title":"Hum Mol Genet"},{"key":"2041_CR52","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","volume":"296","author":"AW Dunah","year":"2002","unstructured":"Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, Hersch SM, Mouradian MM, Young AB et al (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington\u2019s disease. Science 296:2238\u20132243","journal-title":"Science"},{"key":"2041_CR53","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2009","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP et al (2009) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 97:6763\u20136768","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2041_CR54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","volume":"24","author":"CC Huang","year":"1998","unstructured":"Huang CC, Faber PW, Persichetti F, Mittal V, Vonsattel JP, MacDonald ME, Gusella JF (1998) Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat Cell Mol Genet 24:217\u2013233","journal-title":"Somat Cell Mol Genet"},{"key":"2041_CR55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00401-020-02156-4","volume":"140","author":"SR Nath","year":"2020","unstructured":"Nath SR, Lieberman ML, Yu Z, Marchioretti C, Jones ST, Danby ECE, Van Pelt KM, Sorar\u00f9 G et al (2020) MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease. Acta Neuropathol 140:63\u201380","journal-title":"Acta Neuropathol"},{"key":"2041_CR56","doi-asserted-by":"crossref","first-page":"115087","DOI":"10.1016\/j.bmc.2019.115087","volume":"6","author":"Y Asfaha","year":"2019","unstructured":"Asfaha Y, Schrenk C, Alves Avelar LA, Hamacher A, Pflieger M, Kassack MU, Kurz T (2019) Recent advances in class IIa histone deacetylases research. Bioorg Med Chem 6:115087","journal-title":"Bioorg Med Chem"},{"key":"2041_CR57","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1128\/MCB.19.11.7816","volume":"19","author":"AH Wang","year":"1999","unstructured":"Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, Th\u2019ng J, Han J et al (1999) HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 19:7816\u20137827","journal-title":"Mol Cell Biol"},{"key":"2041_CR58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cellsig.2012.10.002","volume":"25","author":"A Clocchiatti","year":"2013","unstructured":"Clocchiatti A, Di E, Demarchi F, Brancolini C (2013) Beside the MEF2 axis : Unconventional functions of HDAC4. Cell Signal 25:269\u2013276","journal-title":"Cell Signal"},{"key":"2041_CR59","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1038\/sj.onc.1210613","volume":"26","author":"M Martin","year":"2007","unstructured":"Martin M, Kettmann R, Dequiedt F (2007) Class IIa histone deacetylases: regulating the regulators. Oncogene 26:5450\u20135467","journal-title":"Oncogene"},{"key":"2041_CR60","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/cne.22241","volume":"518","author":"MJ Darcy","year":"2010","unstructured":"Darcy MJ, Calvin K, Cavnar K, Ouimet CC (2010) Regional and subcellular distribution of HDAC4 in mouse brain. J Comp Neurol 518:722\u2013740","journal-title":"J Comp Neurol"},{"key":"2041_CR61","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2015.09.018","volume":"80","author":"M Adachi","year":"2016","unstructured":"Adachi M, Lin PY, Pranav H, Monteggia LM (2016) Postnatal loss of Mef2c results in dissociation of effects on synapse number and learning and memory. Biol Psychiatry 80:140\u2013148","journal-title":"Biol Psychiatry"},{"key":"2041_CR62","doi-asserted-by":"crossref","first-page":"e34863","DOI":"10.1371\/journal.pone.0034863","volume":"7","author":"MW Akhtar","year":"2012","unstructured":"Akhtar MW, Kim MS, Adachi M, Morris MJ, Qi X, Richardson JA, Bassel-Duby R, Olson EN et al (2012) In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. PLoS One 7:e34863","journal-title":"PLoS One"},{"key":"2041_CR63","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1007\/s12035-018-1363-7","volume":"56","author":"SP Kamath","year":"2019","unstructured":"Kamath SP, Chen AI (2019) Myocyte enhancer factor 2c regulates dendritic complexity and connectivity of cerebellar Purkinje cells. Mol Neurobiol 56:4102\u20134119","journal-title":"Mol Neurobiol"},{"key":"2041_CR64","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mcn.2010.01.012","volume":"44","author":"X Tian","year":"2010","unstructured":"Tian X, Kai L, Hockberger PE, Wokosin DL, Surmeier DJ (2010) MEF-2 regulates activity dependent spine loss in striatopallidal medium spiny neurons. Mol Cell Neurosci 44:94\u2013108","journal-title":"Mol Cell Neurosci"},{"key":"2041_CR65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnmol.2015.00078","volume":"8","author":"K Minatohara","year":"2016","unstructured":"Minatohara K, Akiyoshi M, Okuno H (2016) Role of immediate-early genes in synaptic plasticity and neuronal ensembles underlying the memory trace. Front Mol Neurosci 8:78","journal-title":"Front Mol Neurosci"},{"key":"2041_CR66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1326-6-71","volume":"6","author":"A Giralt","year":"2011","unstructured":"Giralt A, Carret\u00f3n O, Lao-Peregrin C, Mart\u00edn ED, Alberch J (2011) Conditional BDNF release under pathological conditions improves Huntington\u2019s disease pathology by delaying neuronal dysfunction. Mol Neurodegener 6:71","journal-title":"Mol Neurodegener"},{"key":"2041_CR67","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","volume":"106","author":"DA Simmons","year":"2009","unstructured":"Simmons DA, Rex CS, Palmer L, Pandyarajan V, Fedulov V, Gall CM, Lynch G (2009) Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington\u2019s disease knockin mice. Proc Natl Acad Sci U S A 106:4906\u20134911","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2041_CR68","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neubiorev.2019.01.015","volume":"98","author":"Y Glikmann-Johnston","year":"2019","unstructured":"Glikmann-Johnston Y, Fink KD, Deng P, Torrest A, Stout JC (2019) Spatial memory in Huntington's disease: a comparative review of human and animal data. Neurosci Biobehav Rev 98:194\u2013207","journal-title":"Neurosci Biobehav Rev"},{"key":"2041_CR69","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/BF02284844","volume":"25","author":"ME Calhoun","year":"1996","unstructured":"Calhoun ME, Jucker M, Martin LJ, Thinakaran G, Price DL, Mouton PR (1996) Comparative evaluation of synaptophysin-based methods for quantification of synapses. J Neurocytol 25:821\u2013828","journal-title":"J Neurocytol"},{"key":"2041_CR70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1750-3639.1993.tb00729.x","volume":"3","author":"G Thiel","year":"1993","unstructured":"Thiel G (1993) Synapsin I, synapsin II, and synaptophysin: marker proteins of synaptic vesicles. Brain Pathol 3:87\u201395","journal-title":"Brain Pathol"},{"key":"2041_CR71","doi-asserted-by":"crossref","first-page":"e53848","DOI":"10.1371\/journal.pone.0053848","volume":"8","author":"FM Rodr\u00edguez-Tornos","year":"2013","unstructured":"Rodr\u00edguez-Tornos FM, San Aniceto I, Cubelos B, Nieto M (2013) Enrichment of conserved synaptic activity-responsive element in neuronal genes predicts a coordinated response of MEF2, CREB and SRF. PLoS One 8:e53848","journal-title":"PLoS One"},{"key":"2041_CR72","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4161\/cib.3.5.12287","volume":"3","author":"M Inoue","year":"2010","unstructured":"Inoue M, Yagishita-Kyo N, Nonaka M, Kawashima T, Okuno H, Bito H (2010) Synaptic activity responsive element (SARE): a unique genomic structure with an unusual sensitivity to neuronal activity. Commun Integr Biol 3:443\u2013446","journal-title":"Commun Integr Biol"},{"key":"2041_CR73","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1073\/pnas.0806518106","volume":"106","author":"T Kawashima","year":"2009","unstructured":"Kawashima T, Okuno H, Nonaka M, Adachi-Morishima A, Kyo N, Okamura M, Takemoto-Kimura S, Worley PF et al (2009) Synaptic activity-responsive element in the Arc\/Arg3.1 promoter essential for synapse-to-nucleus signaling in activated neurons. Proc Natl Acad Sci U S A 106:316\u2013321","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02041-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-02041-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02041-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T23:58:49Z","timestamp":1628121529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-02041-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2041"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02041-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,5]]},"assertion":[{"value":"22 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}},{"value":"All procedures were approved by the Animal Experimentation Ethics Committee of the University of Barcelona, in compliance with Spanish (RD 53\/2013) and European (2010\/63\/UE) regulations for the care and use of laboratory animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"This manuscript has been approved for publication by all authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}